Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)

Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y) Publisher Pubmed

Najafizadeh SR¹ ; Amiri K¹ ; Moghaddassi M¹ ; Khanmohammadi S¹ ; Mirmiranpour H² ; Nakhjavani M³

Source: Clinical Rheumatology Published:2021

Abstract

In the original published version of this article, a typographical error on co-author’s first name has been changed from Shagayegh Khanmohammadi to “Shaghayegh Khanmohammadi”. The original article has been corrected. © International League of Associations for Rheumatology (ILAR) 2021

Style	Citing Format
MLA	Najafizadeh SR, et al.. "Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)." Clinical Rheumatology, vol. 40, no. 10, 2021, pp. 4027-.
APA	Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M (2021). Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y). Clinical Rheumatology, 40(10), 4027-.
Chicago	Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M. "Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)." Clinical Rheumatology 40, no. 10 (2021): 4027-.
Harvard	Najafizadeh SR et al. (2021) 'Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)', Clinical Rheumatology, 40(10), pp. 4027-.
Vancouver	Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M. Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y). Clinical Rheumatology. 2021;40(10):4027-.
BibTex	@article{ author = {Najafizadeh SR and Amiri K and Moghaddassi M and Khanmohammadi S and Mirmiranpour H and Nakhjavani M}, title = {Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)}, journal = {Clinical Rheumatology}, volume = {40}, number = {10}, pages = {4027-}, year = {2021} }
RIS	TY - JOUR AU - Najafizadeh SR AU - Amiri K AU - Moghaddassi M AU - Khanmohammadi S AU - Mirmiranpour H AU - Nakhjavani M TI - Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y) JO - Clinical Rheumatology VL - 40 IS - 10 SP - 4027 EP - PY - 2021 ER -

Style

Citing Format

MLA

Najafizadeh SR, et al.. "Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)." Clinical Rheumatology, vol. 40, no. 10, 2021, pp. 4027-.

APA

Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M (2021). Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y). Clinical Rheumatology, 40(10), 4027-.

Chicago

Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M. "Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)." Clinical Rheumatology 40, no. 10 (2021): 4027-.

Harvard

Najafizadeh SR et al. (2021) 'Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)', Clinical Rheumatology, 40(10), pp. 4027-.

Vancouver

Najafizadeh SR, Amiri K, Moghaddassi M, Khanmohammadi S, Mirmiranpour H, Nakhjavani M. Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y). Clinical Rheumatology. 2021;40(10):4027-.

BibTex

@article{ author = {Najafizadeh SR and Amiri K and Moghaddassi M and Khanmohammadi S and Mirmiranpour H and Nakhjavani M}, title = {Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)}, journal = {Clinical Rheumatology}, volume = {40}, number = {10}, pages = {4027-}, year = {2021} }

RIS

TY - JOUR
AU - Najafizadeh SR
AU - Amiri K
AU - Moghaddassi M
AU - Khanmohammadi S
AU - Mirmiranpour H
AU - Nakhjavani M
TI - Correction To: Advanced Glycation End Products, Advanced Oxidation Protein Products, and Ferric Reducing Ability of Plasma in Patients With Rheumatoid Arthritis: A Focus on Activity Scores (Clinical Rheumatology, (2021), 40, 10, (4019-4026), 10.1007/S10067-021-05771-Y)
JO - Clinical Rheumatology
VL - 40
IS - 10
SP - 4027
EP -
PY - 2021
ER -

Science Communicator Platform

Authors

Abstract